Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endo Health Solutions Inc Updates FY 2012 Revenue Guidance; Lowers High End Of Prior FY 2012 EPS Guidance To A Range In Line With Analysts' Estimates


Monday, 5 Nov 2012 07:00am EST 

Endo Health Solutions Inc updated its guidance of fiscal 2012. For fiscal 2012, the Company now expects adjusted diluted EPS in the range of $5.00 to $5.10; reported diluted (GAAP) EPS in the range of $0.87 to $0.97; and revenues of approximately $3.05 billion. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $3.10 billion and EPS of $5.03 for fiscal 2012. 

Company Quote

66.91
0.75 +1.13%
2:09pm EDT